Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp von Landenberg

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Auto- Immunity Highlights|May 23, 2015
Toll-like receptors play a crucial part in the pathophysiological activity of antiphospholipid antibodiesPhilipp von Landenberg
Current Opinion in Immunology|December 7, 2007
Nucleic acid recognizing Toll-like receptors and autoimmunityPhilipp von Landenberg, Stefan Bauer
Autoimmunity Reviews|January 15, 2008
Toll-like receptors and autoimmunityJulia Hurst, Philipp von Landenberg
Immunobiology|December 6, 2005
Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infectionKatrin Frauenknecht, Karl Lackner, Philipp von Landenberg
Autoimmunity Reviews|April 7, 2007
Human parvovirus B19 infection and antiphospholipid antibodiesPhilipp von Landenberg, Hartwig W Lehmann, Susanne Modrow
International Urology and Nephrology|December 3, 2021
Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patientsF P Tillmann, H Still, Philipp von Landenberg
Autoimmunity Reviews|July 10, 2003
Parvovirus B19 infection and autoimmune diseaseHartwig W Lehmann, Philipp von Landenberg, Susanne Modrow
Current Rheumatology Reports|April 29, 2010
The roll of Toll-like receptors in the antiphospholipid syndromeJulia Hurst, Mareike Lorenz, Nadine Prinz, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?Philipp von Landenberg, Yvonne Döring, Susanne Modrow, et al.
Immunobiology|March 18, 2003
The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single centerPhilipp von Landenberg, Jürgen Schölmerich, Johannes von Kempis, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Auto- Immunity Highlights|May 23, 2015
Toll-like receptors play a crucial part in the pathophysiological activity of antiphospholipid antibodiesPhilipp von Landenberg
Current Opinion in Immunology|December 7, 2007
Nucleic acid recognizing Toll-like receptors and autoimmunityPhilipp von Landenberg, Stefan Bauer
Autoimmunity Reviews|January 15, 2008
Toll-like receptors and autoimmunityJulia Hurst, Philipp von Landenberg
Immunobiology|December 6, 2005
Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infectionKatrin Frauenknecht, Karl Lackner, Philipp von Landenberg
Autoimmunity Reviews|April 7, 2007
Human parvovirus B19 infection and antiphospholipid antibodiesPhilipp von Landenberg, Hartwig W Lehmann, Susanne Modrow
International Urology and Nephrology|December 3, 2021
Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patientsF P Tillmann, H Still, Philipp von Landenberg
Autoimmunity Reviews|July 10, 2003
Parvovirus B19 infection and autoimmune diseaseHartwig W Lehmann, Philipp von Landenberg, Susanne Modrow
Current Rheumatology Reports|April 29, 2010
The roll of Toll-like receptors in the antiphospholipid syndromeJulia Hurst, Mareike Lorenz, Nadine Prinz, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?Philipp von Landenberg, Yvonne Döring, Susanne Modrow, et al.
Immunobiology|March 18, 2003
The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single centerPhilipp von Landenberg, Jürgen Schölmerich, Johannes von Kempis, et al.
Pageof 5